41 results on '"Schuepbach, Reto"'
Search Results
2. Reduced anticoagulation strategy is associated with a lower incidence of intracerebral hemorrhage in COVID-19 patients on extracorporeal membrane oxygenation
- Author
-
Hofmaenner, Daniel A., Furfaro, David, Wild, Lennart C., Wendel-Garcia, Pedro David, Baedorf Kassis, Elias, Pannu, Ameeka, Welte, Tobias, Erlebach, Rolf, Stahl, Klaus, Grandin, Edward Wilson, Putensen, Christian, Schuepbach, Reto A., Shaefi, Shahzad, David, Sascha, Seeliger, Benjamin, and Bode, Christian
- Published
- 2023
- Full Text
- View/download PDF
3. Coagulation side effects of enzymatic debridement in burned patients
- Author
-
Pfister, Pablo, Garcia Wendel, Pedro David, Kim, Bong Sung, Schuepbach, Reto Andreas, Steiger, Peter, Camen, Giovanni, and Buehler, Philipp Karl
- Published
- 2023
- Full Text
- View/download PDF
4. The Angiopoietin-2/Angiopoietin-1 ratio increases early in burn patients and predicts mortality
- Author
-
Heuberger, Dorothea, Wendel-Garcia, Pedro David, Sazpinar, Onur, Müller, Mattia, Klein, Holger, Kim, Bong-Sung, Andermatt, Rea, Erlebach, Rolf, Schuepbach, Reto A., Buehler, Philipp K., David, Sascha, and Hofmaenner, Daniel A.
- Published
- 2023
- Full Text
- View/download PDF
5. Machine learning using the extreme gradient boosting (XGBoost) algorithm predicts 5-day delta of SOFA score at ICU admission in COVID-19 patients
- Author
-
Alfaro-Farias, Mario, Vizmanos-Lamotte, Gerardo, Tschoellitsch, Thomas, Meier, Jens, Aguirre-Bermeo, Hernán, Apolo, Janina, Martínez, Alberto, Jurkolow, Geoffrey, Delahaye, Gauthier, Novy, Emmanuel, Losser, Marie-Reine, Wengenmayer, Tobias, Rilinger, Jonathan, Staudacher, Dawid L., David, Sascha, Welte, Tobias, Stahl, Klaus, Pavlos”, “Agios, Aslanidis, Theodoros, Korsos, Anita, Babik, Barna, Nikandish, Reza, Rezoagli, Emanuele, Giacomini, Matteo, Nova, Alice, Fogagnolo, Alberto, Spadaro, Savino, Ceriani, Roberto, Murrone, Martina, Wu, Maddalena A., Cogliati, Chiara, Colombo, Riccardo, Catena, Emanuele, Turrini, Fabrizio, Simonini, Maria Sole, Fabbri, Silvia, Potalivo, Antonella, Facondini, Francesca, Gangitano, Gianfilippo, Perin, Tiziana, Grazia Bocci, Maria, Antonelli, Massimo, Gommers, Diederik, Rodríguez-García, Raquel, Gámez-Zapata, Jorge, Taboada-Fraga, Xiana, Castro, Pedro, Tellez, Adrian, Lander-Azcona, Arantxa, Escós-Orta, Jesús, Martín-Delgado, Maria C., Algaba-Calderon, Angela, Franch-Llasat, Diego, Roche-Campo, Ferran, Lozano-Gómez, Herminia, Zalba-Etayo, Begoña, Michot, Marc P., Klarer, Alexander, Ensner, Rolf, Schott, Peter, Urech, Severin, Zellweger, Nuria, Merki, Lukas, Lambert, Adriana, Laube, Marcus, Jeitziner, Marie M., Jenni-Moser, Beatrice, Wiegand, Jan, Yuen, Bernd, Lienhardt-Nobbe, Barbara, Westphalen, Andrea, Salomon, Petra, Drvaric, Iris, Hillgaertner, Frank, Sieber, Marianne, Dullenkopf, Alexander, Petersen, Lina, Chau, Ivan, Ksouri, Hatem, Sridharan, Govind Oliver, Cereghetti, Sara, Boroli, Filippo, Pugin, Jerome, Grazioli, Serge, Rimensberger, Peter C., Bürkle, Christian, Marrel, Julien, Brenni, Mirko, Fleisch, Isabelle, Lavanchy, Jerome, Perez, Marie-Helene, Ramelet, Anne-Sylvie, Weber, Anja Baltussen, Gerecke, Peter, Christ, Andreas, Ceruti, Samuele, Glotta, Andrea, Marquardt, Katharina, Shaikh, Karim, Hübner, Tobias, Neff, Thomas, Redecker, Hermann, Moret-Bochatay, Mallory, Bentrup, FriederikeMeyer zu, Studhalter, Michael, Stephan, Michael, Brem, Jan, Gehring, Nadine, Selz, Daniela, Naon, Didier, Kleger, Gian-Reto, Pietsch, Urs, Filipovic, Miodrag, Ristic, Anette, Sepulcri, Michael, Heise, Antje, Franchitti Laurent, Marilene, Laurent, Jean-Christophe, Wendel Garcia, Pedro D., Schuepbach, Reto, Heuberger, Dorothea, Bühler, Philipp, Brugger, Silvio, Fodor, Patricia, Locher, Pascal, Camen, Giovanni, Gaspert, Tomislav, Jovic, Marija, Haberthuer, Christoph, Lussman, Roger F., Colak, Elif, Montomoli, Jonathan, Romeo, Luca, Moccia, Sara, Bernardini, Michele, Migliorelli, Lucia, Berardini, Daniele, Donati, Abele, Carsetti, Andrea, Bocci, Maria Grazia, Wendel Garcia, Pedro David, Fumeaux, Thierry, Guerci, Philippe, Schüpbach, Reto Andreas, Ince, Can, Frontoni, Emanuele, and Hilty, Matthias Peter
- Published
- 2021
- Full Text
- View/download PDF
6. mRNA-based SARS-CoV-2 vaccination is associated with reduced ICU admission rate and disease severity in critically ill COVID-19 patients treated in Switzerland
- Author
-
Hilty, Matthias Peter, Keiser, Stefanie, Wendel Garcia, Pedro D., Moser, André, Schuepbach, Reto A., Hilty, Matthias P., and Schüpbach, Reto A.
- Subjects
Vaccination ,Messenger RNA ,Health care industry - Abstract
Author(s): Matthias Peter Hilty [sup.1], Stefanie Keiser [sup.1], Pedro D. Wendel Garcia [sup.1], André Moser [sup.2], Reto A. Schuepbach [sup.1], Matthias P. Hilty, Reto A. Schüpbach, Pedro D. Wendel Garcia, [...]
- Published
- 2022
- Full Text
- View/download PDF
7. Dynamics of disease characteristics and clinical management of critically ill COVID-19 patients over the time course of the pandemic: an analysis of the prospective, international, multicentre RISC-19-ICU registry
- Author
-
Wendel-Garcia, Pedro David, Moser, André, Jeitziner, Marie-Madlen, Aguirre-Bermeo, Hernán, Arias-Sanchez, Pedro, Apolo, Janina, Roche-Campo, Ferran, Franch-Llasat, Diego, Kleger, Gian-Reto, Schrag, Claudia, Pietsch, Urs, Filipovic, Miodrag, David, Sascha, Stahl, Klaus, Bouaoud, Souad, Ouyahia, Amel, Fodor, Patricia, Locher, Pascal, Siegemund, Martin, Zellweger, Nuria, Cereghetti, Sara, Schott, Peter, Gangitano, Gianfilippo, Wu, Maddalena Alessandra, Alfaro-Farias, Mario, Vizmanos-Lamotte, Gerardo, Ksouri, Hatem, Gehring, Nadine, Rezoagli, Emanuele, Turrini, Fabrizio, Lozano-Gómez, Herminia, Carsetti, Andrea, Rodríguez-García, Raquel, Yuen, Bernd, Weber, Anja Baltussen, Castro, Pedro, Escos-Orta, Jesus Oscar, Dullenkopf, Alexander, Martín-Delgado, Maria C., Aslanidis, Theodoros, Perez, Marie-Helene, Hillgaertner, Frank, Ceruti, Samuele, Franchitti Laurent, Marilene, Marrel, Julien, Colombo, Riccardo, Laube, Marcus, Fogagnolo, Alberto, Studhalter, Michael, Wengenmayer, Tobias, Gamberini, Emiliano, Buerkle, Christian, Buehler, Philipp K., Keiser, Stefanie, Elhadi, Muhammed, Montomoli, Jonathan, Guerci, Philippe, Fumeaux, Thierry, Schuepbach, Reto A., Jakob, Stephan M., Que, Yok-Ai, and Hilty, Matthias Peter
- Published
- 2022
- Full Text
- View/download PDF
8. Long-term ketamine infusion-induced cholestatic liver injury in COVID-19-associated acute respiratory distress syndrome
- Author
-
Wendel-Garcia, Pedro David, Erlebach, Rolf, Hofmaenner, Daniel Andrea, Camen, Giovanni, Schuepbach, Reto Andreas, Jüngst, Christoph, Müllhaupt, Beat, Bartussek, Jan, Buehler, Philipp Karl, Andermatt, Rea, and David, Sascha
- Published
- 2022
- Full Text
- View/download PDF
9. Microcirculatory alterations in critically ill COVID-19 patients analyzed using artificial intelligence
- Author
-
Hilty, Matthias Peter, Favaron, Emanuele, Wendel Garcia, Pedro David, Ahiska, Yavuz, Uz, Zuhre, Akin, Sakir, Flick, Moritz, Arbous, Sesmu, Hofmaenner, Daniel A., Saugel, Bernd, Endeman, Henrik, Schuepbach, Reto Andreas, and Ince, Can
- Published
- 2022
- Full Text
- View/download PDF
10. Development and validation of a prognostic model for the early identification of COVID-19 patients at risk of developing common long COVID symptoms
- Author
-
Deforth, Manja, Gebhard, Caroline E., Bengs, Susan, Buehler, Philipp K., Schuepbach, Reto A., Zinkernagel, Annelies S., Brugger, Silvio D., Acevedo, Claudio T., Patriki, Dimitri, Wiggli, Benedikt, Twerenbold, Raphael, Kuster, Gabriela M., Pargger, Hans, Schefold, Joerg C., Spinetti, Thibaud, Wendel-Garcia, Pedro D., Hofmaenner, Daniel A., Gysi, Bianca, Siegemund, Martin, Heinze, Georg, Regitz-Zagrosek, Vera, Gebhard, Catherine, and Held, Ulrike
- Published
- 2022
- Full Text
- View/download PDF
11. The importance of intravenous immunoglobulin treatment in critically ill patients with necrotizing soft tissue infection: a retrospective cohort study
- Author
-
Hofmaenner, Daniel A., Wendel Garcia, Pedro David, Blum, Manuel R., David, Sascha, Schuepbach, Reto A., Buehler, Philipp K., Frey, Pascal M., Zinkernagel, Annelies S., and Brugger, Silvio D.
- Published
- 2022
- Full Text
- View/download PDF
12. Use of eye tracking in analyzing distribution of visual attention among critical care nurses in daily professional life: an observational study
- Author
-
Hofmaenner, Daniel A., Herling, Anique, Klinzing, Stephanie, Wegner, Stephan, Lohmeyer, Quentin, Schuepbach, Reto A., and Buehler, Philipp K.
- Published
- 2021
- Full Text
- View/download PDF
13. POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients (POSITiVE) II—study protocol of a randomized clinical trial.
- Author
-
Bernardi, Martin H., Bettex, Dominique, Buiteman–Kruizinga, Laura A., de Bie, Ashley, Hoffmann, Matthias, de Kleijn, Janine, Serafini, Simon Corrado, Molenaar, Manon A., Paulus, Frederique, Peršec, Jasminka, Neto, Ary Serpa, Schuepbach, Reto, Severgnini, Paolo, Šribar, Andrej, Schultz, Marcus J., Tschernko, Edda, and for the POSITiVE II–investigators
- Subjects
RESEARCH protocols ,VENTILATION ,CARDIAC surgery ,CARDIAC patients - Abstract
Background: One single-center randomized clinical trial showed that INTELLiVENT-adaptive support ventilation (ASV) is superior to conventional ventilation with respect to the quality of ventilation in post-cardiac surgery patients. Other studies showed that this automated ventilation mode reduces the number of manual interventions at the ventilator in various types of critically ill patients. In this multicenter study in patients post-cardiac surgery, we test the hypothesis that INTELLiVENT-ASV is superior to conventional ventilation with respect to the quality of ventilation. Methods: "POStoperative INTELLiVENT-adaptive support VEntilation in cardiac surgery patients II (POSITiVE II)" is an international, multicenter, two-group randomized clinical superiority trial. In total, 328 cardiac surgery patients will be randomized. Investigators screen patients aged > 18 years of age, scheduled for elective cardiac surgery, and expected to receive postoperative ventilation in the ICU for longer than 2 h. Patients either receive automated ventilation by means of INTELLiVENT-ASV or ventilation that is not automated by means of a conventional ventilation mode. The primary endpoint is quality of ventilation, defined as the proportion of postoperative ventilation time characterized by exposure to predefined optimal, acceptable, and critical (injurious) ventilatory parameters in the first two postoperative hours. One major secondary endpoint is ICU team staff workload, captured by the ventilator software collecting manual settings on alarms. Patient-centered endpoints include duration of postoperative ventilation and length of stay in ICU. Discussion: POSITiVE II is the first international, multicenter, randomized clinical trial designed to confirm that POStoperative INTELLiVENT-ASV is superior to non-automated conventional ventilation and secondary to determine if this closed-loop ventilation mode reduces ICU team staff workload. The results of POSITiVE II will support intensive care teams in their choices regarding the use of automated ventilation in postoperative care of uncomplicated cardiac surgery patients. Trial registration: Clinicaltrials.gov NCT06178510. Registered on December 4, 2023. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
14. Intracranial Hemorrhages on Extracorporeal Membrane Oxygenation: Differences Between COVID-19 and Other Viral Acute Respiratory Distress Syndrome
- Author
-
Seeliger, Benjamin, Doebler, Michael, Hofmaenner, Daniel Andrea, Wendel-Garcia, Pedro D., Schuepbach, Reto A., Schmidt, Julius J., Welte, Tobias, Hoeper, Marius M., Gillmann, Hans-Jörg, Kuehn, Christian, Ehrentraut, Stefan Felix, Schewe, Jens-Christian, Putensen, Christian, Stahl, Klaus, Bode, Christian, and David, Sascha
- Published
- 2022
- Full Text
- View/download PDF
15. Carboxyhemoglobin predicts oxygenator performance and imminent oxygenator change in extracorporeal membrane oxygenation.
- Author
-
Erlebach, Rolf, Buhlmann, Alix, Andermatt, Rea, Seeliger, Benjamin, Stahl, Klaus, Bode, Christian, Schuepbach, Reto, Wendel-Garcia, Pedro David, David, Sascha, Kleinert, Eva-Maria, Hofmaenner, Daniel Andrea, Müller, Mattia M, Ganter, Christoph Camille, Welte, Tobias, Pape, Thorben, Rath, Ann-Kathrin, Nalbant, Bahar, Ruwisch, Jannik, Putensen, Christian, and Peukert, Konrad
- Subjects
EXTRACORPOREAL membrane oxygenation ,OXYGENATORS ,CARBOXYHEMOGLOBIN ,ERYTHROCYTES ,LYSIS - Abstract
Background: The continuous exposure of blood to a non-biological surface during extracorporeal membrane oxygenation (ECMO) may lead to progressive thrombus formation in the oxygenator, hemolysis and consequently impaired gas exchange. In most centers oxygenator performance is monitored only on a once daily basis. Carboxyhemoglobin (COHb) is generated upon red cell lysis and is routinely measured with any co-oximetry performed to surveille gas exchange and acid–base homeostasis every couple of hours. This retrospective cohort study aims to evaluate COHb in the arterial blood gas as a novel marker of oxygenator dysfunction and its predictive value for imminent oxygenator change. Results: Out of the 484 screened patients on ECMO 89, cumulatively requiring 116 oxygenator changes within 1833 patient days, including 19,692 arterial COHb measurements were analyzed. Higher COHb levels were associated with lower post-oxygenator pO
2 (estimate for log(COHb): − 2.176 [95% CI − 2.927, − 1.427], p < 0.0001) and with a shorter time to oxygenator change (estimate for log(COHb): − 67.895 [95% CI − 74.209, − 61.542] hours, p < 0.0001). COHb was predictive of oxygenator change within 6 h (estimate for log(COHb): 5.027 [95% CI 1.670, 15.126], p = 0.004). Conclusion: COHb correlates with oxygenator performance and can be predictive of imminent oxygenator change. Therefore, longitudinal measurements of COHb in clinical routine might be a cheap and more granular candidate for ECMO surveillance that should be further analyzed in a controlled prospective trial design. [ABSTRACT FROM AUTHOR]- Published
- 2024
- Full Text
- View/download PDF
16. Early sevoflurane sedation in severe COVID-19-related lung injury patients. A pilot randomized controlled trial.
- Author
-
Beck-Schimmer, Beatrice, Schadde, Erik, Pietsch, Urs, Filipovic, Miodrag, Dübendorfer-Dalbert, Seraina, Fodor, Patricia, Hübner, Tobias, Schuepbach, Reto, Steiger, Peter, David, Sascha, Krüger, Bernard D., Neff, Thomas A., and Schläpfer, Martin
- Subjects
LUNG disease treatment ,VASCULAR endothelial growth factors ,PEARSON correlation (Statistics) ,SEVOFLURANE ,EARLY medical intervention ,RESEARCH funding ,CRITICALLY ill ,PATIENTS ,THERAPEUTICS ,RENAL replacement therapy ,CREATININE ,INFLAMMATORY mediators ,T-test (Statistics) ,CYTOKINE release syndrome ,MULTIPLE organ failure ,PILOT projects ,STATISTICAL sampling ,SEX distribution ,SEVERITY of illness index ,RANDOMIZED controlled trials ,TERTIARY care ,HOSPITAL mortality ,DESCRIPTIVE statistics ,ACUTE kidney failure ,CALCITONIN ,CHI-squared test ,MANN Whitney U Test ,TREATMENT duration ,OPERATIVE surgery ,LUNG diseases ,ARTIFICIAL respiration ,DRUG efficacy ,RESEARCH ,INTRAVENOUS anesthesia ,INTENSIVE care units ,UREA ,ONE-way analysis of variance ,COMPARATIVE studies ,VASOCONSTRICTORS ,LENGTH of stay in hospitals ,ADVERSE health care events ,ANESTHESIA ,COVID-19 ,INTERLEUKINS ,C-reactive protein ,CELL receptors ,DISEASE incidence ,EVALUATION ,BLOOD - Abstract
Background: This study aimed to assess a potential organ protective effect of volatile sedation in a scenario of severe inflammation with an early cytokine storm (in particular IL-6 elevation) in patients suffering from COVID-19-related lung injury with invasive mechanical ventilation and sedation. Methods: This is a small-scale pilot multicenter randomized controlled trial from four tertiary hospitals in Switzerland, conducted between April 2020 and May 2021. 60 patients requiring mechanical ventilation due to severe COVID-19-related lung injury were included and randomized to 48-hour sedation with sevoflurane vs. continuous intravenous sedation (= control) within 24 h after intubation. The primary composite outcome was determined as mortality or persistent organ dysfunction (POD), defined as the need for mechanical ventilation, vasopressors, or renal replacement therapy at day 28. Secondary outcomes were the length of ICU and hospital stay, adverse events, routine laboratory parameters (creatinine, urea), and plasma inflammatory mediators. Results: 28 patients were randomized to sevoflurane, 32 to the control arm. The intention-to-treat analysis revealed no difference in the primary endpoint with 11 (39%) sevoflurane and 13 (41%) control patients (p = 0.916) reaching the primary outcome. Five patients died within 28 days in each group (16% vs. 18%, p = 0.817). Of the 28-day survivors, 6 (26%) and 8 (30%) presented with POD (p = 0.781). There was a significant difference regarding the need for vasopressors (1 (4%) patient in the sevoflurane arm, 7 (26%) in the control one (p = 0.028)). Length of ICU stay, hospital stay, and registered adverse events within 28 days were comparable, except for acute kidney injury (AKI), with 11 (39%) sevoflurane vs. 2 (6%) control patients (p = 0.001). The blood levels of IL-6 in the first few days after the onset of the lung injury were less distinctly elevated than expected. Conclusions: No evident benefits were observed with short sevoflurane sedation on mortality and POD. Unexpectedly low blood levels of IL-6 might indicate a moderate injury with therefore limited improvement options of sevoflurane. Acute renal issues suggest caution in using sevoflurane for sedation in COVID-19. Trial registration: The trial was registered on ClinicalTrials.gov (NCT04355962) on 2020/04/21. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Former smoking, but not active smoking, is associated with delirium in postoperative ICU patients: a matched case-control study.
- Author
-
Komninou, Maria Angeliki, Egli, Simon, Rossi, Aurelio, Ernst, Jutta, Krauthammer, Michael, Schuepbach, Reto A., Delgado, Marcos, and Bartussek, Jan
- Subjects
NICOTINE replacement therapy ,DELIRIUM ,SURGICAL intensive care ,CASE-control method ,SMOKING ,LOGISTIC regression analysis ,INTENSIVE care units ,INHALATION injuries - Abstract
Objective: To examine the relationship between current and former smoking and the occurrence of delirium in surgical Intensive Care Unit (ICU) patients. Methods: We conducted a single center, case-control study involving 244 delirious and 251 non-delirious patients that were admitted to our ICU between 2018 and 2022. Using propensity score analysis, we obtained 115 pairs of delirious and non-delirious patients matched for age and Simplified Acute Physiology Score II (SAPS II). Both groups of patients were further stratified into non-smokers, active smokers and former smokers, and logistic regression was performed to further investigate potential confounders. Results: Our study revealed a significant association between former smoking and the incidence of delirium in ICU patients, both in unmatched (adjusted odds ratio (OR): 1.82, 95% confidence interval (CI): 1.17-2.83) and matched cohorts (OR: 3.0, CI: 1.53-5.89). Active smoking did not demonstrate a significant difference in delirium incidence compared to non-smokers (unmatched OR = 0.98, CI: 0.62-1.53, matched OR = 1.05, CI: 0.55-2.0). Logistic regression analysis of the matched group confirmed former smoking as an independent risk factor for delirium, irrespective of other variables like surgical history (p = 0.010). Notably, also respiratory and vascular surgeries were associated with increased odds of delirium (respiratory: OR: 4.13, CI: 1.73-9.83; vascular: OR: 2.18, CI: 1.03-4.59). Medication analysis showed that while Ketamine and Midazolam usage did not significantly correlate with delirium, Morphine use was linked to a decreased likelihood (OR: 0.27, 95% CI: 0.13-0.55). Discussion: Nicotine's complex neuropharmacological impact on the brain is still not fully understood, especially its short-term and long-term implications for critically ill patients. Although our retrospective study cannot establish causality, our findings suggest that smoking may induce structural changes in the brain, potentially heightening the risk of postoperative delirium. Intriguingly, this effect seems to be obscured in active smokers, potentially due to the recognized neuroprotective properties of nicotine. Our results motivate future prospective studies, the results of which hold the potential to substantially impact risk assessment procedures for surgeries. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
18. Group A Streptococcus strains causing meningitis without distinct invasive phenotype.
- Author
-
Marquardt, Laura, Andreoni, Federica, Boumasmoud, Mathilde, Schweizer, Tiziano A., Heuberger, Dorothea M., Parietti, Elena, Hertegonne, Sanne, Epprecht, Jana, Mattle, Dario, Raez, Anna K., Marques‐Maggio, Ewerton, Schuepbach, Reto A., Hasse, Barbara, Mairpady‐Shambat, Srikanth, Brugger, Silvio D., and Zinkernagel, Annelies S.
- Published
- 2024
- Full Text
- View/download PDF
19. Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.
- Author
-
Gebhard, Caroline E., Sütsch, Claudia, Gebert, Pimrapat, Gysi, Bianca, Bengs, Susan, Todorov, Atanas, Deforth, Manja, Buehler, Philipp K., Meisel, Alexander, Schuepbach, Reto A., Zinkernagel, Annelies S., Brugger, Silvio D., Acevedo, Claudio, Patriki, Dimitri, Wiggli, Benedikt, Beer, Jürg H., Friedl, Andrée, Twerenbold, Raphael, Kuster, Gabriela M., and Pargger, Hans
- Published
- 2024
- Full Text
- View/download PDF
20. Quantification of within-patient Staphylococcus aureus phenotypic heterogeneity as a proxy for the presence of persisters across clinical presentations
- Author
-
Bär, Julian, Boumasmoud, Mathilde, Mairpady Shambat, Srikanth, Vulin, Clément, Huemer, Markus, Schweizer, Tiziano A., Gómez-Mejia, Alejandro, Eberhard, Nadia, Achermann, Yvonne, Zingg, Patrick O., Mestres, Carlos A., Brugger, Silvio D., Schuepbach, Reto A., Kouyos, Roger D., Hasse, Barbara, and Zinkernagel, Annelies S.
- Published
- 2022
- Full Text
- View/download PDF
21. The phenomenon of desorption: What are the best adsorber exchange intervals?
- Author
-
Buhlmann, Alix, Erlebach, Rolf, Müller, Mattia, David, Sascha, Kleinert, Eva-Maria, Andermatt, Rea, Hofmaenner, Daniel Andrea, Mueller, Mattia, Schuepbach, Reto, Wendel-Garcia, Pedro David, Ganter, Christoph Camille, Stahl, Klaus, Welte, Tobias, Pape, Thorben, Rath, Ann-Kathrin, Nalbant, Bahar, Ruwisch, Jannik, Bode, Christian, Seeliger, Benjamin, and Putensen, Christian
- Published
- 2024
- Full Text
- View/download PDF
22. Indications and Outcomes of Patients Receiving Therapeutic Plasma Exchange under Critical Care Conditions: A Retrospective Eleven-Year Single-Center Study at a Tertiary Care Center.
- Author
-
Ring, Alexander, Sieber, Wolfgang Alexander, Studt, Jan-Dirk, Schuepbach, Reto A., Ganter, Christoph Camille, Manz, Markus Gabriel, Müller, Antonia Maria Susanne, and David, Sascha
- Subjects
PLASMA exchange (Therapeutics) ,CRITICAL care medicine ,TERTIARY care ,RENAL replacement therapy ,INTENSIVE care units - Abstract
Background: Therapeutic plasma exchange (TPE) is frequently performed in critical care settings for heterogenous indications. However, specific intensive care unit (ICU) data regarding TPE indications, patient characteristics and technical details are sparse. Methods: We performed a retrospective, single-center study using data from January 2010 until August 2021 for patients treated with TPE in an ICU setting at the University Hospital Zurich. Data collected included patient characteristics and outcomes, ICU-specific parameters, as well as apheresis-specific technical parameters and complications. Results: We identified n = 105 patients receiving n = 408 TPEs for n = 24 indications during the study period. The most common was thrombotic microangiopathies (TMA) (38%), transplant-associated complications (16.3%) and vasculitis (14%). One-third of indications (35.2%) could not be classified according to ASFA. Anaphylaxis was the most common TPE-related complication (6.7%), while bleeding complications were rare (1%). The median duration of ICU stay was 8 ± 14 days. Ventilator support, renal replacement therapy or vasopressors were required in 59 (56.2%), 26 (24.8%), and 35 (33.3%) patients, respectively, and 6 (5.7%) patients required extracorporeal membrane oxygenation. The overall hospital survival rate was 88.6%. Conclusion: Our study provides valuable real-world data on heterogenous TPE indications for patients in the ICU setting, potentially supporting decision-making. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. EXCHANGE-2: investigating the efficacy of add-on plasma exchange as an adjunctive strategy against septic shock—a study protocol for a randomized, prospective, multicenter, open-label, controlled, parallel-group trial.
- Author
-
David, Sascha, Bode, Christian, Stahl, Klaus, Schmidt, Julius, Seeliger, Benjamin, Pape, Thorben, Schmidt, Bernhard, Hoeper, Marius M., Wedemeyer, Heiner, Welte, Tobias, Schmidt-Ott, Kai, Wendel Garcia, Pedro David, Hofmänner, Daniel A., Andermatt, Rea, Schuepbach, Reto, Bankova, Andriyana, Gillmann, Hans-Joerg, Stueber, Thomas, Jung, Carolin, and Gerdes, Andre
- Subjects
SEPTIC shock ,PLASMA exchange (Therapeutics) ,BLOOD volume ,RESEARCH protocols ,PLASMA products ,CLINICAL trials - Abstract
Background: Sepsis is as a life-threatening organ dysfunction caused by a dysregulated host response to an infection. The mortality of sepsis and particular of septic shock is very high. Treatment mostly focuses on infection control but a specific intervention that targets the underlying pathological host response is lacking to the present time. The investigators hypothesize that early therapeutic plasma exchange (TPE) will dampen the maladaptive host response by removing injurious mediators thereby limiting organ dysfunction and improving survival in patients with septic shock. Although small prospective studies demonstrated rapid hemodynamic stabilization under TPE, no adequately powered randomized clinical trial has investigated hard outcomes. Methods: This is a randomized, prospective, multicenter, open-label, controlled, parallel-group interventional trial to test the adjunctive effect of TPE in patients with early septic shock. Patients with a refractory (defined as norepinephrine (NE) ≥ 0.4 μg/kg/min ≥ 30 min OR NE 0.3 μg/kg/min + vasopressin) and early (shock onset < 24 h) septic shock will be included. The intervention is a standard TPE with donor fresh frozen plasma (1.2 × individual plasma volume) performed within 6 h after randomization and will be compared to a standard of care (SOC) control arm. The primary endpoint is 28 days mortality for which the power analysis revealed a group size of 137 / arm (n = 274) to demonstrate a benefit of 15%. The key secondary objective will be to compare the extent of organ failure indicated by mean SOFA over the first 7 days as well as organ support-free days until day 28 following randomization. Besides numerous biological secondary, safety endpoints such as incidence of bleeding, allergic reactions, transfusion associated lung injury, severe thrombocytopenia, and other severe adverse events will be assessed during the first 7 days. For exploratory scientific analyses, biomaterial will be acquired longitudinally and multiple predefined scientific subprojects are planned. This study is an investigator-initiated trial supported by the German Research Foundation (DFG, DA 1209/7–1), in which 26 different centers in Germany, Switzerland, and Austria will participate over a duration of 33 months. Discussion: This trial has substantial clinical relevance as it evaluates a promising adjunctive treatment option in refractory septic shock patients suffering from an extraordinary high mortality. A positive trial result could change the current standard of care for this septic subgroup. The results of this study will be disseminated through presentations at international congresses, workshops, and peer-reviewed publications. Trial registration: ClinicalTrials.gov NCT05726825, Registered on 14 February 2023. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
24. Effects of tall man lettering on the visual behaviour of critical care nurses while identifying syringe drug labels: a randomised in situ simulation.
- Author
-
Lohmeyer, Quentin, Schiess, Cornel, Garcia, Pedro David Wendel, Petry, Heidi, Strauch, Eric, Dietsche, Andreas, Schuepbach, Reto A., Buehler, Philipp K., and Hofmaenner, Daniel A.
- Subjects
MEDICATION error prevention ,INTENSIVE care units ,SYRINGES ,INTENSIVE care nursing ,ACADEMIC medical centers ,CONFIDENCE intervals ,SIMULATION methods in education ,CRITICAL care nurses ,RANDOMIZED controlled trials ,EYE movement measurements ,DRUG labeling ,ATTENTION ,QUESTIONNAIRES ,DESCRIPTIVE statistics ,STATISTICAL models ,STATISTICAL sampling ,DATA analysis software ,EDUCATIONAL outcomes ,LONGITUDINAL method - Abstract
Background Patients in intensive care units are prone to the occurrence of medication errors. Look-alike, sound-alike drugs with similar drug names can lead to medication errors and therefore endanger patient safety. Capitalisation of distinct text parts in drug names might facilitate differentiation of medication labels. The aim of this study was to test whether the use of such 'tall man' lettering (TML) reduces the error rate and to examine effects on the visual attention of critical care nurses while identifying syringe labels. Methods This was a prospective, randomised in situ simulation conducted at the University Hospital Zurich, Zurich, Switzerland. Under observation by eye tracking, 30 nurses were given 10 successive tasks involving the presentation of a drug name and its selection from a dedicated set of 10 labelled syringes that included look-alike and sound-alike drug names, half of which had TML-coded labels. Error rate as well as dwell time, fixation count, fixation duration and revisits were analysed using a linear mixed-effects model analysis to compare TML-coded with non-TML-coded labels. Results TML coding of syringe labels led to a significant decrease in the error rate (from 5.3% (8 of 150 in non-TML-coded sets) to 0.7% (1 of 150 in TML-coded sets), p<0.05). Eye tracking further showed that TML affects visual attention, resulting in longer dwell time (p<0.01), more and longer fixations (p<0.05 and p<0.01, respectively) on the drug name as well as more frequent revisits (p<0.01) compared with non-TML-coded labels. Detailed analysis revealed that these effects were stronger for labels using TML in the mid-to-end position of the drug name. Conclusions TML in drug names changes visual attention while identifying syringe labels and supports critical care nurses in preventing medication errors. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. Sex versus gender-related characteristics: which predicts clinical outcomes of acute COVID-19?
- Author
-
Gebhard, Caroline E., Hamouda, Nadia, Gebert, Pimrapat, Regitz-Zagrosek, Vera, Gebhard, Catherine, on behalf of the COGEN Investigators, Bengs, Susan, Gysi, Bianca, Dussault-Cloutier, Arnaud, Buehler, Karl Philipp, Schuepbach, Reto A., Zinkernagel, Annelies S., Brugger, Silvio D., Acevedo, Claudio, Patriki, Dimitri, Wiggli, Benedikt, Beer, Jürg H., Friedl, Andrée, Twerenbold, Raphael, and Kuster, Gabriela M.
- Published
- 2022
- Full Text
- View/download PDF
26. High-Affinity Cu(I)-Chelator with Potential Anti-Tumorigenic Action—A Proof-of-Principle Experimental Study of Human H460 Tumors in the CAM Assay.
- Author
-
Heuberger, Dorothea M., Wolint, Petra, Jang, Jae-Hwi, Itani, Saria, Jungraithmayr, Wolfgang, Waschkies, Conny F., Meier-Bürgisser, Gabriella, Andreoli, Stefano, Spanaus, Katharina, Schuepbach, Reto A., Calcagni, Maurizio, Fahrni, Christoph J., and Buschmann, Johanna
- Subjects
TREATMENT of lung tumors ,COPPER metabolism ,EXPERIMENTAL design ,CHELATION therapy ,ANALYSIS of variance ,IMMUNOHISTOCHEMISTRY ,CELL physiology ,CELL receptors ,FISHER exact test ,CELL survival ,DESCRIPTIVE statistics ,PATHOLOGIC neovascularization ,BIOLOGICAL assay ,DATA analysis software - Abstract
Simple Summary: Lung cancer is a serious burden worldwide. The growth of lung tumors depends on vessel density and intratumoral copper concentration. Copper chelating agents can reduce copper content in tumor tissue, resulting in lower vessel density and lower tumor weight. PSP-2, a very potent copper chelator, was tested on lung tumor grafts that were on-planted on the chorioallantoic membrane of the chicken embryo. We found a lower vessel density and a lower tumor weight under PSP-2 application compared to the controls. Thus, PSP-2 could be a potential therapeutic agent to treat lung cancer in the future. Human lung cancer ranks among the most frequently treated cancers worldwide. As copper appears critical to angiogenesis and tumor growth, selective removal of copper represents a promising strategy to restrict tumor growth. To this end, we explored the activity of the novel high-affinity membrane-permeant Cu(I) chelator PSP-2 featuring a low-zeptomolar dissociation constant. Using H460 human lung cancer cells, we generated small tumors on the chorioallantoic membrane of the chicken embryo (CAM assay) and studied the effects of topical PSP-2 application on their weight and vessel density after one week. We observed a significant angiosuppression along with a marked decrease in tumor weight under PSP-2 application compared to controls. Moreover, PSP-2 exposure resulted in lower ki67
+ cell numbers at a low dose but increased cell count under a high dose. Moreover, HIF-1α+ cells were significantly reduced with low-dose PSP-2 exposure compared to high-dose and control. The total copper content was considerably lower in PSP-2 treated tumors, although statistically not significant. Altogether, PSP-2 shows promising potential as an anti-cancer drug. Nevertheless, further animal experiments and application to different tumor types are mandatory to support these initial findings, paving the way toward clinical trials. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
27. Renal Tubular Acidosis in Pregnant Critically Ill COVID-19 Patients: A Secondary Analysis of a Prospective Cohort.
- Author
-
Humbel, Simona, Wendel-Garcia, Pedro David, Unseld, Simone, Noll, Fabienne, Schuepbach, Reto Andreas, Ganter, Christoph Camille, Seeger, Harald, David, Sascha, and Andermatt, Rea
- Subjects
COVID-19 ,RENAL tubular transport disorders ,CRITICALLY ill ,SECONDARY analysis ,ACIDOSIS ,INTENSIVE care units - Abstract
Background: Renal tubular acidosis (RTA) is an extremely rare cause of metabolic acidosis (10 in 100,000). RTA has been linked neither to pregnancy nor to severe coronavirus disease 2019 (COVID-19). The purpose of this study was to analyze the prevalence and clinical course of normal anion gap metabolic acidosis in critically ill pregnant COVID-19 patients and to compare them to an age-matched nonpregnant female patient cohort. Methods: Secondary analysis was conducted on a prospective observational cohort of critically ill patients suffering from COVID-19 consecutively admitted to a tertiary intensive care unit (ICU) between February 2020 and April 2021. Results: A total of 321 COVID-19 patients required admission to the ICU; 95 (30%) were female, and 18 (19%) were of childbearing age. Seven of eight (88%) pregnant women (all in the last trimester) required advanced respiratory support due to COVID-19. The estimated glomerular filtration rate was 135 (123–158) mL/min/m
2 body surface area, and six pregnant women (86%) were diagnosed with a normal, respiratory compensated, anion gap metabolic acidosis (pHmin 7.3 (7.18–7.31), HCO3 − min 14.8 (12.8–18.6) mmol/L, and paCO2 3.4 (3.3–4.5) kPa). Three (43%) acidotic pregnant women fulfilled diagnostic criteria for RTA. All women recovered spontaneously within less 7 days. Conclusions: Metabolic acidosis seems to be very common (85%) in pregnant critically ill COVID-19 patients, and the prevalence of RTA might be higher than normal. It remains to be demonstrated if this observation is an indirect epiphenomenon or due to a direct viral effect on the tubular epithelium. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
28. Correction: Early sevoflurane sedation in severe COVID19-related lung injury patients. A pilot randomized controlled trial.
- Author
-
Beck-Schimmer, Beatrice, Schadde, Erik, Pietsch, Urs, Filipovic, Miodrag, Dübendorfer-Dalbert, Seraina, Fodor, Patricia, Hübner, Tobias, Schuepbach, Reto, Steiger, Peter, David, Sascha, Krüger, Bernard D., Neff, Thomas A., and Schläpfer, Martin
- Subjects
SEVOFLURANE ,LUNG injuries ,SEVERITY of illness index ,ANESTHESIA ,COVID-19 - Published
- 2024
- Full Text
- View/download PDF
29. Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease.
- Author
-
Busnadiego, Idoia, Abela, Irene A., Frey, Pascal M., Hofmaenner, Daniel A., Scheier, Thomas C., Schuepbach, Reto A., Buehler, Philipp K., Brugger, Silvio D., and Hale, Benjamin G.
- Subjects
AUTOANTIBODIES ,IMMUNOGLOBULIN M ,TYPE I interferons ,HERPESVIRUS diseases ,SARS-CoV-2 ,COVID-19 ,HUMAN herpesvirus 1 - Abstract
Autoantibodies neutralizing the antiviral action of type I interferons (IFNs) have been associated with predisposition to severe Coronavirus Disease 2019 (COVID-19). Here, we screened for such autoantibodies in 103 critically ill COVID-19 patients in a tertiary intensive care unit (ICU) in Switzerland. Eleven patients (10.7%), but no healthy donors, had neutralizing anti-IFNα or anti-IFNα/anti-IFNω IgG in plasma/serum, but anti-IFN IgM or IgA was rare. One patient had nonneutralizing anti-IFNα IgG. Strikingly, all patients with plasma anti-IFNα IgG also had anti-IFNα IgG in tracheobronchial secretions, identifying these autoantibodies at anatomical sites relevant for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection. Longitudinal analyses revealed patient heterogeneity in terms of increasing, decreasing, or stable anti-IFN IgG levels throughout the length of hospitalization. Notably, presence of anti-IFN autoantibodies in this critically ill COVID-19 cohort appeared to predict herpesvirus disease (caused by herpes simplex viruses types 1 and 2 (HSV-1/-2) and/or cytomegalovirus (CMV)), which has been linked to worse clinical outcomes. Indeed, all 7 tested COVID-19 patients with anti-IFN IgG in our cohort (100%) suffered from one or more herpesviruses, and analysis revealed that these patients were more likely to experience CMV than COVID-19 patients without anti-IFN autoantibodies, even when adjusting for age, gender, and systemic steroid treatment (odds ratio (OR) 7.28, 95% confidence interval (CI) 1.14 to 46.31, p = 0.036). As the IFN system deficiency caused by neutralizing anti-IFN autoantibodies likely directly and indirectly exacerbates the likelihood of latent herpesvirus reactivations in critically ill patients, early diagnosis of anti-IFN IgG could be rapidly used to inform risk-group stratification and treatment options. Trial Registration: ClinicalTrials.gov Identifier: NCT04410263. Autoantibodies that neutralize the antiviral action of type I interferons are associated with predisposition to severe COVID-19. This study shows that this deficiency in the interferon system is associated with a heightened risk of herpesvirus disease in critically ill patients infected with SARS-CoV-2. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
30. Severe Toxic Epidermal Necrolysis and Drug Reaction with Eosinophilia and Systemic Symptoms Overlap Syndrome Treated with Benralizumab: A Case Report.
- Author
-
Zeller, Felix K., Bader, Patrick R., Nägeli, Mirjam C., Buehler, Philipp K., and Schuepbach, Reto A.
- Subjects
TOXIC epidermal necrolysis ,CRITICALLY ill patient care ,EOSINOPHILIA ,INTENSIVE care patients ,SYMPTOMS - Abstract
TEN/DRESS overlap syndrome can be difficult to diagnose, especially if it is masked by comorbidities in critically ill patients in intensive care units. The existing therapy for the two conditions is also a major challenge for the treating team. A possible alternative, especially for refractory cases, is benralizumab as an IL-5-receptor alpha-chain-specific humanized monoclonal antibody (IgG1k). We are able to show a successful treatment in this case report. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
31. Hyperinflammatory environment drives dysfunctional myeloid cell effector response to bacterial challenge in COVID-19.
- Author
-
Mairpady Shambat, Srikanth, Gómez-Mejia, Alejandro, Schweizer, Tiziano A., Huemer, Markus, Chang, Chun-Chi, Acevedo, Claudio, Bergada-Pijuan, Judith, Vulin, Clément, Hofmaenner, Daniel A., Scheier, Thomas C., Hertegonne, Sanne, Parietti, Elena, Miroshnikova, Nataliya, Wendel Garcia, Pedro D., Hilty, Matthias P., Buehler, Philipp Karl, Schuepbach, Reto A., Brugger, Silvio D., and Zinkernagel, Annelies S.
- Subjects
MYELOID cells ,COVID-19 ,CELL receptors ,IMMUNE response ,CRITICALLY ill children ,BACTERIAL diseases - Abstract
COVID-19 displays diverse disease severities and symptoms including acute systemic inflammation and hypercytokinemia, with subsequent dysregulation of immune cells. Bacterial superinfections in COVID-19 can further complicate the disease course and are associated with increased mortality. However, there is limited understanding of how SARS-CoV-2 pathogenesis and hypercytokinemia impede the innate immune function against bacterial superinfections. We assessed the influence of COVID-19 plasma hypercytokinemia on the functional responses of myeloid immune cells upon bacterial challenges from acute-phase COVID-19 patients and their corresponding recovery (rec)-phase. We show that a severe hypercytokinemia status in COVID-19 patients correlates with the development of bacterial superinfections. Neutrophils and monocytes derived from COVID-19 patients in their acute-phase showed an impaired intracellular microbicidal capacity upon bacterial challenges. The impaired microbicidal capacity was reflected by abrogated MPO and reduced NETs production in neutrophils along with reduced ROS production in both neutrophils and monocytes. Moreover, we observed a distinct pattern of cell surface receptor expression on both neutrophils and monocytes, in line with suppressed autocrine and paracrine cytokine signaling. This phenotype was characterized by a high expression of CD66b, CXCR4 and low expression of CXCR1, CXCR2 and CD15 in neutrophils and low expression of HLA-DR, CD86 and high expression of CD163 and CD11b in monocytes. Furthermore, the impaired antibacterial effector function was mediated by synergistic effect of the cytokines TNF-α, IFN-γ and IL-4. COVID-19 patients receiving dexamethasone showed a significant reduction of overall inflammatory markers in the plasma as well as exhibited an enhanced immune response towards bacterial challenge ex vivo. Finally, broad anti-inflammatory treatment was associated with a reduction in CRP, IL-6 levels as well as length of ICU and hospital stay in critically ill COVID-19 patients. Our data provides insights into the transient functional dysregulation of myeloid immune cells against subsequent bacterial infections in COVID-19 patients and describe a beneficial role for the use of dexamethasone in these patients. Author summary: COVID-19 caused by SARS-CoV-2 induces immune-paralysis characterized by misdirected host responses and altered levels of inflammatory mediators. Additionally, bacterial superinfections can further exacerbate the disease. Here, we report an in-depth functional characterization of the effector response and phenotypic properties of neutrophils and monocytes derived from critically ill COVID-19 patients towards bacterial superinfection. We show that elevated levels of specific cytokine clusters, positively correlate with the development of bacterial superinfections in these patients. Neutrophils and monocytes of critically ill COVID-19 patients showed impaired bactericidal capacity, which was mediated by elevated inflammatory mediators in the plasma. The observed impaired bactericidal capacity in critically ill COVID-19 patients was due to reduced classical effector functions of neutrophils and monocytes. Interestingly, lower levels of overall inflammatory mediators as well as reduction in length of ICU and hospital stay in critically ill COVID-19 patients treated with dexamethasone was observed. These data suggest that the exhaustion and paralysis of the cellular innate immunity against bacterial challenge in critically ill COVID-19 patients is driven by a misdirected host-response, characterized by a hyperinflammatory environment including dysregulated cytokine levels. These results further emphasize the utility and importance of dampening these inflammatory mediators via broad anti-inflammatory therapy in COVID-19 patients, which improves the antibacterial effector functions of neutrophils and monocytes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
32. Blunted sFasL signalling exacerbates TNF‐driven neutrophil necroptosis in critically ill COVID‐19 patients.
- Author
-
Schweizer, Tiziano A, Mairpady Shambat, Srikanth, Vulin, Clement, Hoeller, Sylvia, Acevedo, Claudio, Huemer, Markus, Gomez‐Mejia, Alejandro, Chang, Chun‐Chi, Baum, Jeruscha, Hertegonne, Sanne, Hitz, Eva, Scheier, Thomas C, Hofmaenner, Daniel A, Buehler, Philipp K, Moch, Holger, Schuepbach, Reto A, Brugger, Silvio D, and Zinkernagel, Annelies S
- Subjects
COVID-19 ,TUMOR necrosis factor receptors ,CORONAVIRUS diseases ,TOXIC epidermal necrolysis ,CRITICALLY ill ,THREONINE ,NEUTROPHILS ,PROTEIN kinases ,LYSIS - Abstract
Objectives: Critically ill coronavirus disease 2019 (COVID‐19) patients are characterised by a severely dysregulated cytokine profile and elevated neutrophil counts, impacting disease severity. However, it remains unclear how neutrophils contribute to pathophysiology during COVID‐19. Here, we assessed the impact of the dysregulated cytokine profile on the regulated cell death (RCD) programme of neutrophils. Methods: Regulated cell death phenotype of neutrophils isolated from critically ill COVID‐19 patients or healthy donors and stimulated with COVID‐19 or healthy plasma ex vivo was assessed by flow cytometry, time‐lapse microscopy and cytokine multiplex analysis. Immunohistochemistry of COVID‐19 patients and control biopsies were performed to assess the in situ neutrophil RCD phenotype. Plasma cytokine levels of COVID‐19 patients and healthy donors were measured by multiplex analysis. Clinical parameters were correlated to cytokine levels of COVID‐19 patients. Results: COVID‐19 plasma induced a necroptosis‐sensitive neutrophil phenotype, characterised by cell lysis, elevated release of damage‐associated molecular patterns (DAMPs), increased receptor‐interacting serine/threonine‐protein kinase (RIPK) 1 levels and mixed lineage kinase domain‐like pseudokinase (MLKL) involvement. The occurrence of neutrophil necroptosis MLKL axis was further confirmed in COVID‐19 thrombus and lung biopsies. Necroptosis was induced by the tumor necrosis factor receptor 1 (TNFRI)/TNF‐α axis. Moreover, reduction of soluble Fas ligand (sFasL) levels in COVID‐19 patients and hence decreased signalling to Fas directly increased RIPK1 levels, exacerbated TNF‐driven necroptosis and correlated with disease severity, which was abolished in patients treated with glucocorticoids. Conclusion: Our results suggest a novel role for sFasL signalling in the TNF‐α‐induced RCD programme in neutrophils during COVID‐19 and a potential therapeutic target to curb inflammation and thus influence disease severity and outcome. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
33. Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS.
- Author
-
Garcia, Pedro David Wendel, Andrea Hofmaenner, Daniel, Brugger, Silvio D., Acevedo, Claudio T., Bartussek, Jan, Camen, Giovanni, Bader, Patrick Raphael, Bruellmann, Gregor, Kattner, Johannes, Ganter, Christoph, Schuepbach, Reto Andreas, and Buehler, Philipp Karl
- Subjects
ARTIFICIAL respiration ,COVID-19 pandemic ,LUNGS ,BODY weight ,CLINICAL trials - Abstract
Background: Lung-protective ventilation is key in bridging patients suffering from COVID-19 acute respiratory distress syndrome (ARDS) to recovery. However, resource and personnel limitations during pandemics complicate the implementation of lung-protective protocols. Automated ventilation modes may prove decisive in these settings enabling higher degrees of lungprotective ventilation than conventional modes. Method: Prospective study at a Swiss university hospital. Critically ill, mechanically ventilated COVID-19 ARDS patients were allocated, by study-blinded coordinating staff, to either closed-loop or conventional mechanical ventilation, based on mechanical ventilator availability. Primary outcome was the overall achieved percentage of lung-protective ventilation in closed-loop versus conventional mechanical ventilation, assessed minute-by-minute, during the initial 7 days and overall mechanical ventilation time. Lung-protective ventilation was defined as the combined target of tidal volume <8 ml per kg of ideal body weight, dynamic driving pressure <15 cmH
2 O, peak pressure <30 cmH2 O, peripheral oxygen saturation -88% and dynamic mechanical power <17 J/min. Results: Forty COVID-19 ARDS patients, accounting for 1,048,630 minutes (728 days) of cumulative mechanical ventilation, allocated to either closed-loop (n = 23) or conventional ventilation (n = 17), presenting with a median paO2 /FiO2 ratio of 92 [72-147] mmHg and a static compliance of 18 [11-25] ml/cmH2 O, were mechanically ventilated for 11 [4-25] days and had a 28-day mortality rate of 20%. During the initial 7 days of mechanical ventilation, patients in the closed-loop group were ventilated lung-protectively for 65% of the time versus 38% in the conventional group (Odds Ratio, 1.79; 95% CI, 1.76-1.82; P < 0.001) and for 45% versus 33% of overall mechanical ventilation time (Odds Ratio, 1.22; 95% CI, 1.21-1.23; P < 0.001). Conclusion: Among critically ill, mechanically ventilated COVID-19 ARDS patients during an early highpoint of the pandemic, mechanical ventilation using a closed-loop mode was associated with a higher degree of lung-protective ventilation than was conventional mechanical ventilation. [ABSTRACT FROM AUTHOR]- Published
- 2021
- Full Text
- View/download PDF
34. Perioperative targeted temperature management of severely burned patients by means of an oesophageal temperature probe.
- Author
-
Furrer, Florian, Wendel-Garcia, Pedro David, Pfister, Pablo, Hofmaenner, Daniel Andrea, Franco, Carlos, Sachs, Alexandra, Fleischer, Juliane, Both, Christian, Kim, Bong Sun, Schuepbach, Reto A., Steiger, Peter, Camen, Giovanni, and Buehler, Philipp Karl
- Subjects
- *
BODY surface area , *INDUCED hypothermia , *HEAT exchangers , *BURN patients , *TEMPERATURE , *HEAT transfer - Abstract
Hypothermia in severely burned patients is associated with a significant increase in morbidity and mortality. The use of an oesophageal heat exchanger tube (EHT) can improve perioperative body temperatures in severely burned patients. The aim of this study was to investigate the intraoperative warming effect of oesophageal heat transfer in severe burn patients. Single-centre retrospective study performed at the Burns Centre of the University Hospital Zurich. Between January 2020 and May 2021 perioperative temperature management with EHT was explored in burned patients with a total body surface area (TBSA) larger than 30%. Data from patients, who received perioperative temperature management by EHT, were compared to data from the same patients during interventions performed under standard temperature management matching for length and type of intervention. A total of 30 interventions (15 with and 15 without EHT) in 10 patients were analysed. Patient were 38 [26−48] years of age, presented with severe burns covering a median of 50 [42−64] % TBSA and were characterized by an ABSI of 10 [8−12] points. When receiving EHT management patients experienced warming at 0.07 °C per minute (4.2 °C/h) compared to a temperature loss of − 0.03 °C per minute (1.8 °C/h) when only receiving standard temperature management (p < 0.0001). No adverse or serious adverse events were reported. The use of an oesophageal heat transfer device was effective and safe in providing perioperative warming to severely burned patients when compared to a standard temperature management protocol. By employing an EHT as primary temperature management device perioperative hypothermia in severely burned patients can possibly be averted, potentially leading to reduced hypothermia-associated complications. • EHT was associated with intraoperative warming as opposed to standard temperature management. • This study shows that the use of an EHT was effective and safe. • EHT can potentially leading to reduced hypothermia-associated complications. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
35. Where do ICU trainees really look? An eye-tracking analysis of gaze patterns during central venous catheter insertion.
- Author
-
Buehler PK, Wendel-Garcia PD, Müller M, Schmidt MT, Schuepbach RA, Lohmeyer Q, and Hofmaenner DA
- Abstract
Background: There is limited knowledge about gaze patterns of intensive care unit (ICU) trainee doctors during the insertion of a central venous catheter (CVC). The primary objective of this study was to examine visual patterns exhibited by ICU trainee doctors during CVC insertion. Additionally, the study investigated whether differences in gaze patterns could be identified between more and less experienced trainee doctors., Methods: In a real-life, prospective observational study conducted at the interdisciplinary ICU at the University Hospital Zurich, Switzerland, ICU trainee doctors underwent eye-tracking during CVC insertion in a real ICU patient. Using mixed-effects model analyses, the primary outcomes were dwell time, first fixation duration, revisits, fixation count, and average fixation time on different areas of interest (AOI). Secondary outcomes were above eye-tracking outcome measures stratified according to experience level of participants., Results: Eighteen participants were included, of whom 10 were inexperienced and eight more experienced. Dwell time was highest for CVC preparation table ( p = 0.02), jugular vein on ultrasound image ( p < 0.001) and cervical puncture location ( p < 0.001). Concerning experience, dwell time and revisits on jugular vein on ultrasound image ( p = 0.02 and p = 0.04, respectively) and cervical puncture location ( p = 0.004 and p = 0.01, respectively) were decreased in more experienced ICU trainees., Conclusions: Various AOIs have distinct significance for ICU trainee doctors during CVC insertion. Experienced participants exhibited different gaze behavior, requiring less attention for preparation and handling tasks, emphasizing the importance of hand-eye coordination., Competing Interests: Declaration of conflicting interestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.
- Published
- 2024
- Full Text
- View/download PDF
36. Impact of sex and gender on post-COVID-19 syndrome, Switzerland, 2020.
- Author
-
Gebhard CE, Sütsch C, Gebert P, Gysi B, Bengs S, Todorov A, Deforth M, Buehler PK, Meisel A, Schuepbach RA, Zinkernagel AS, Brugger SD, Acevedo C, Patriki D, Wiggli B, Beer JH, Friedl A, Twerenbold R, Kuster GM, Pargger H, Tschudin-Sutter S, Schefold JC, Spinetti T, Henze C, Pasqualini M, Sager DF, Mayrhofer L, Grieder M, Tontsch J, Franzeck FC, Wendel Garcia PD, Hofmaenner DA, Scheier T, Bartussek J, Haider A, Grämer M, Mikail N, Rossi A, Zellweger N, Opić P, Portmann A, von Känel R, Pazhenkottil AP, Messerli M, Buechel RR, Kaufmann PA, Treyer V, Siegemund M, Held U, Regitz-Zagrosek V, and Gebhard C
- Subjects
- Female, Humans, Male, Adult, Middle Aged, Post-Acute COVID-19 Syndrome, Switzerland epidemiology, Prospective Studies, SARS-CoV-2, Disease Progression, COVID-19 epidemiology
- Abstract
BackgroundWomen are overrepresented among individuals with post-acute sequelae of SARS-CoV-2 infection (PASC). Biological (sex) as well as sociocultural (gender) differences between women and men might account for this imbalance, yet their impact on PASC is unknown.AimWe assessed the impact of sex and gender on PASC in a Swiss population.MethodOur multicentre prospective cohort study included 2,856 (46% women, mean age 44.2 ± 16.8 years) outpatients and hospitalised patients with PCR-confirmed SARS-CoV-2 infection.ResultsAmong those who remained outpatients during their first infection, women reported persisting symptoms more often than men (40.5% vs 25.5% of men; p < 0.001). This sex difference was absent in hospitalised patients. In a crude analysis, both female biological sex (RR = 1.59; 95% CI: 1.41-1.79; p < 0.001) and a score summarising gendered sociocultural variables (RR = 1.05; 95% CI: 1.03-1.07; p < 0.001) were significantly associated with PASC. Following multivariable adjustment, biological female sex (RR = 0.96; 95% CI: 0.74-1.25; p = 0.763) was outperformed by feminine gender-related factors such as a higher stress level (RR = 1.04; 95% CI: 1.01-1.06; p = 0.003), lower education (RR = 1.16; 95% CI: 1.03-1.30; p = 0.011), being female and living alone (RR = 1.91; 95% CI: 1.29-2.83; p = 0.001) or being male and earning the highest income in the household (RR = 0.76; 95% CI: 0.60-0.97; p = 0.030).ConclusionSpecific sociocultural parameters that differ in prevalence between women and men, or imply a unique risk for women, are predictors of PASC and may explain, at least in part, the higher incidence of PASC in women. Once patients are hospitalised during acute infection, sex differences in PASC are no longer evident.
- Published
- 2024
- Full Text
- View/download PDF
37. Critical care staffing ratio and outcome of COVID-19 patients requiring intensive care unit admission during the first pandemic wave: a retrospective analysis across Switzerland from the RISC-19-ICU observational cohort.
- Author
-
Jeitziner MM, Moser A, Wendel-Garcia PD, Exl MT, Keiser S, Schuepbach RA, Pietsch U, Cereghetti S, Boroli F, Marrel J, Sigg AA, Ksouri H, Schott P, Dullenkopf A, Fleisch I, Heise A, Laurent JC, Jakob SM, Hilty MP, and Que YA
- Subjects
- Critical Care, Critical Illness therapy, Hospital Mortality, Humans, Intensive Care Units, Retrospective Studies, Switzerland epidemiology, Workforce, COVID-19, Pandemics
- Abstract
Study Aim: The surge of admissions due to severe COVID-19 increased the patients-to-critical care staffing ratio within the ICUs. We investigated whether the daily level of staffing was associated with an increased risk of ICU mortality (primary endpoint), length of stay (LOS), mechanical ventilation and the evolution of disease (secondary endpoints)., Methods: We employed a retrospective multicentre analysis of the international Risk Stratification in COVID-19 patients in the ICU (RISC-19-ICU) registry, limited to the period between March 1 and May 31, 2020, and to Switzerland. Hierarchical regression models were used to investigate crude and adjusted effects of the critical care staffing ratio on study endpoints. We adjusted for disease severity and weekly caseload., Results: Among the 38 participating Swiss ICUs, 17 recorded staffing information. The study population included 437 patients and 2,342 daily assessments of patient-to-critical care staffing ratio. Median of daily patient-to-nurse ratio started at 1.0 [IQR 0.5-1.5; calendar week 9] and peaked at 2.4 (IQR 0.4-2.0; calendar week 16), while the median of daily patient-to-physician ratio started at 4.0 (IQR 2.1-5.0; calendar week 9) and peaked at 6.8 (IQR 6.3-7.3; calendar week 19). Neither the patient-to-nurse (adjusted OR 1.28, 95% CI 0.85-1.93; doubling of ratio) nor the patient-to-physician ratio (adjusted OR 1.07, 95% CI 0.87-1.32; doubling of ratio) were associated with ICU mortality. We found no association of daily critical care staffing on the secondary endpoints in adjusted models., Conclusion: We found no association of reduced availability of critical care staffing resources in Swiss ICUs with overall ICU length of stay nor mortality. Whether long-term outcome of critically ill patients with COVID-19 have been affected remains to be studied.
- Published
- 2022
- Full Text
- View/download PDF
38. Long-Term Persisting SARS-CoV-2 RNA and Pathological Findings: Lessons Learnt From a Series of 35 COVID-19 Autopsies.
- Author
-
Maccio U, Zinkernagel AS, Schuepbach R, Probst-Mueller E, Frontzek K, Brugger SD, Hofmaenner DA, Moch H, and Varga Z
- Abstract
Background: Long-term sequelae of coronavirus disease 2019 (COVID-19), including the interaction between persisting viral-RNA and specific tissue involvement, pose a challenging issue. In this study, we addressed the chronological correlation (after first clinical diagnosis and postmortem) between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA and organ involvement., Methods: The presence of postmortem SARS-CoV-2 RNA from 35 complete COVID-19 autopsies was correlated with the time interval between the first diagnosis of COVID-19 and death and with its relationship to morphologic findings., Results: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RNA can be evident up to 40 days after the first diagnosis and can persist to 94 hours after death. Postmortem SARS-CoV-2 RNA was mostly positive in lungs (70%) and trachea (69%), but all investigated organs were positive with variable frequency. Late-stage tissue damage was evident up to 65 days after initial diagnosis in several organs. Positivity for SARS-CoV-2 RNA in pulmonary swabs correlated with diffuse alveolar damage ( p = 0.0009). No correlation between positive swabs and other morphologic findings was present. Cerebral ( p = 0.0003) and systemic hemorrhages ( p = 0.009), cardiac thrombi ( p = 0.04), and ischemic events ( p = 0.03) were more frequent in the first wave, whereas bacterial pneumonia ( p = 0.03) was more prevalent in the second wave. No differences in biometric data, clinical comorbidities, and other autopsy findings were found., Conclusions: Our data provide evidence not only of long-term postmortem persisting SARS-CoV-2 RNA but also of tissue damage several weeks after the first diagnosis of SARS-CoV-2 infection. Additional conditions, such as concomitant bacterial pulmonary superinfection, lung aspergillosis, thromboembolic phenomena, and hemorrhages can further worsen tissue damage., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2022 Maccio, Zinkernagel, Schuepbach, Probst-Mueller, Frontzek, Brugger, Hofmaenner, Moch and Varga.)
- Published
- 2022
- Full Text
- View/download PDF
39. Closed-Loop Versus Conventional Mechanical Ventilation in COVID-19 ARDS.
- Author
-
Wendel Garcia PD, Hofmaenner DA, Brugger SD, Acevedo CT, Bartussek J, Camen G, Bader PR, Bruellmann G, Kattner J, Ganter C, Schuepbach RA, and Buehler PK
- Subjects
- Humans, Prospective Studies, Respiration, Artificial, SARS-CoV-2, Tidal Volume, COVID-19, Respiratory Distress Syndrome therapy
- Abstract
Background: Lung-protective ventilation is key in bridging patients suffering from COVID-19 acute respiratory distress syndrome (ARDS) to recovery. However, resource and personnel limitations during pandemics complicate the implementation of lung-protective protocols. Automated ventilation modes may prove decisive in these settings enabling higher degrees of lung-protective ventilation than conventional modes., Method: Prospective study at a Swiss university hospital. Critically ill, mechanically ventilated COVID-19 ARDS patients were allocated, by study-blinded coordinating staff, to either closed-loop or conventional mechanical ventilation, based on mechanical ventilator availability. Primary outcome was the overall achieved percentage of lung-protective ventilation in closed-loop versus conventional mechanical ventilation, assessed minute-by-minute, during the initial 7 days and overall mechanical ventilation time. Lung-protective ventilation was defined as the combined target of tidal volume <8 ml per kg of ideal body weight, dynamic driving pressure <15 cmH
2 O, peak pressure <30 cmH2 O, peripheral oxygen saturation ≥88% and dynamic mechanical power <17 J/min., Results: Forty COVID-19 ARDS patients, accounting for 1,048,630 minutes (728 days) of cumulative mechanical ventilation, allocated to either closed-loop (n = 23) or conventional ventilation (n = 17), presenting with a median paO2 / FiO2 ratio of 92 [72-147] mmHg and a static compliance of 18 [11-25] ml/cmH2 O, were mechanically ventilated for 11 [4-25] days and had a 28-day mortality rate of 20%. During the initial 7 days of mechanical ventilation, patients in the closed-loop group were ventilated lung-protectively for 65% of the time versus 38% in the conventional group (Odds Ratio, 1.79; 95% CI, 1.76-1.82; P < 0.001) and for 45% versus 33% of overall mechanical ventilation time (Odds Ratio, 1.22; 95% CI, 1.21-1.23; P < 0.001)., Conclusion: Among critically ill, mechanically ventilated COVID-19 ARDS patients during an early highpoint of the pandemic, mechanical ventilation using a closed-loop mode was associated with a higher degree of lung-protective ventilation than was conventional mechanical ventilation.- Published
- 2021
- Full Text
- View/download PDF
40. Differing Visual Behavior Between Inexperienced and Experienced Critical Care Nurses While Using a Closed-Loop Ventilation System-A Prospective Observational Study.
- Author
-
Buehler PK, Herling A, Bienefeld N, Klinzing S, Wegner S, Wendel Garcia PD, Karbach M, Lohmeyer Q, Schaubmayr E, Schuepbach RA, and Hofmaenner DA
- Abstract
Introduction: Closed-loop ventilation modes are increasingly being used in intensive care units to ensure more automaticity. Little is known about the visual behavior of health professionals using these ventilation modes. The aim of this study was to analyze gaze patterns of intensive care nurses while ventilating a patient in the closed-loop mode with Intellivent adaptive support ventilation® (I-ASV) and to compare inexperienced with experienced nurses. Materials and Methods: Intensive care nurses underwent eye-tracking during daily care of a patient ventilated in the closed-loop ventilation mode. Five specific areas of interest were predefined (ventilator settings, ventilation curves, numeric values, oxygenation Intellivent, ventilation Intellivent). The main independent variable and primary outcome was dwell time. Secondary outcomes were revisits, average fixation time, first fixation and fixation count on areas of interest in a targeted tracking-time of 60 min. Gaze patterns were compared between I-ASV inexperienced ( n = 12) and experienced ( n = 16) nurses. Results: In total, 28 participants were included. Overall, dwell time was longer for ventilator settings and numeric values compared to the other areas of interest. Similar results could be obtained for the secondary outcomes. Visual fixation of oxygenation Intellivent and ventilation Intellivent was low. However, dwell time, average fixation time and first fixation on oxygenation Intellivent were longer in experienced compared to inexperienced intensive care nurses. Discussion: Gaze patterns of intensive care nurses were mainly focused on numeric values and settings. Areas of interest related to traditional mechanical ventilation retain high significance for intensive care nurses, despite use of closed-loop mode. More visual attention to oxygenation Intellivent and ventilation Intellivent in experienced nurses implies more routine and familiarity with closed-loop modes in this group. The findings imply the need for constant training and education with new tools in critical care, especially for inexperienced professionals., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Buehler, Herling, Bienefeld, Klinzing, Wegner, Wendel Garcia, Karbach, Lohmeyer, Schaubmayr, Schuepbach and Hofmaenner.)
- Published
- 2021
- Full Text
- View/download PDF
41. How to Synchronize Longitudinal Patient Data With the Underlying Disease Progression: A Pilot Study Using the Biomarker CRP for Timing COVID-19.
- Author
-
Maibach MA, Allam A, Hilty MP, Perez Gonzalez NA, Buehler PK, Wendel Garcia PD, Brugger SD, Ganter CC, Krauthammer M, Schuepbach RA, and Bartussek J
- Abstract
The continued digitalization of medicine has led to an increased availability of longitudinal patient data that allows the investigation of novel and known diseases in unprecedented detail. However, to accurately describe any underlying pathophysiology and allow inter-patient comparisons, individual patient trajectories have to be synchronized based on temporal markers. In this pilot study, we use longitudinal data from critically ill ICU COVID-19 patients to compare the commonly used alignment markers "onset of symptoms," "hospital admission," and "ICU admission" with a novel objective method based on the peak value of the inflammatory marker C-reactive protein (CRP). By applying our CRP-based method to align the progression of neutrophils and lymphocytes, we were able to define a pathophysiological window that improved mortality risk stratification in our COVID-19 patient cohort. Our data highlights that proper synchronization of longitudinal patient data is crucial for accurate interpatient comparisons and the definition of relevant subgroups. The use of objective temporal disease markers will facilitate both translational research efforts and multicenter trials., Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest., (Copyright © 2021 Maibach, Allam, Hilty, Perez Gonzalez, Buehler, Wendel Garcia, Brugger, Ganter, The CoViD-19 ICU-Research Group Zurich, The RISC-19-ICU Investigators, Krauthammer, Schuepbach and Bartussek.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.